Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/26550

Title:	Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens.
Authors:	Senni, Michele McMurray, John J V Wachter, Rolf McIntyre, Hugh F Reyes, Antonio Majercak, Ivan Andreka, Peter Shehova-Yankova, Nina Anand, Inder Yilmaz, Mehmet B Gogia, Harinder Martinez-Selles, Manuel Fischer, Steffen Zilahi, Zsolt Cosmi, Franco Gelev, Valeri Galve, Enrique Gómez-Doblas,Juan José Nociar, Jan Radomska, Maria Sokolova, Beata Volterrani, Maurizio Sarkar, Arnab Reimund, Bernard Chen, Fabian Charney, Alan View more
Keywords:	ARNI Heart failure LCZ696 Sacubitril Tolerability Valsartan View more
Mesh:	Aged Aminobutyrates Angiotensin Receptor Antagonists Double-Blind Method Female Heart Failure Humans Hyperkalemia Hypotension Male Middle Aged Neprilysin Renal Insufficiency Tetrazoles Treatment Outcome View more
Issue Date:	2016
Citation:	Eur. J. Heart Fail..2016 09;(18)9:1193-202
Abstract:	To assess the tolerability of initiating/uptitrating sacubitril/valsartan (LCZ696) from 50 to 200 mg twice daily (target dose) over 3 and 6 weeks in heart failure (HF) patients (ejection fraction ≤35%).
PMID:	27170530
URI:	https://hdl.handle.net/20.500.12530/26550
Rights:	openAccess
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. General U. Gregorio Marañón > Artículos

Files in This Item:

File	Description	Size	Format
PMC5084812.pdf		512.43 kB	Adobe PDF	View/Open